Research Article: Efficacy of anti-PD-1 monotherapy for recurrent or metastatic olfactory neuroblastoma
Abstract:
Background: Olfactory neuroblastoma (ONB) is a rare malignant tumor of the head and neck. Due to its rarity, standard systemic therapy for this condition has yet to be established. In particular, the use of immune checkpoint inhibitors (ICIs) for the recurrent or metastatic (R/M) ONB population remains unclear.
No summary available.